NCT04915183 2026-03-09
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
Clinical Trials
54 trialsNCT04767984 2026-01-21
Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis
Northwestern University
Phase 2 Active not recruiting
NCT06553157 2026-01-20
Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy
Minia University
Phase 1/2 Completed
NCT05559164 2025-11-14
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT02958852 2025-09-10
ABC-SE
Lund University Hospital
Phase 2 Completed
NCT02603328 2025-08-22
AT CASH EPOC
University of Chicago
Phase 1/2 Completed
NCT04379999 2025-08-07
Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
Fox Chase Cancer Center
Phase EARLY_PHASE1 Completed
NCT03819101 2025-06-26
PEACE-4
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Recruiting
NCT02943590 2025-05-15
STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
Massachusetts General Hospital
Phase 2 Completed
NCT04789057 2025-05-08
Captain
Medical University of Bialystok
Phase 4 Recruiting
NCT06102863 2025-04-29
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Peking University People's Hospital
Phase 2 Recruiting
NCT03127631 2025-01-31
RADICALPC
McMaster University
Phase NA Recruiting
NCT06785974 2025-01-22
SPIRAL
Erasmus Medical Center
Phase 4 Not yet recruiting
NCT03024684 2024-11-12
SHOT
Chiayi Christian Hospital
Phase 4 Active not recruiting
NCT03872388 2024-10-02
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT05675787 2024-07-11
Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Peking University People's Hospital
Phase 2 Recruiting
NCT04862260 2024-05-22
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma
CHU de Quebec-Universite Laval
Phase EARLY_PHASE1 Active not recruiting
NCT06327451 2024-03-25
Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
Tianjin Medical University General Hospital
Phase 2 Recruiting
NCT03560882 2024-03-21
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
University of Kansas Medical Center
Phase 1 Active not recruiting
NCT03830164 2023-10-17
Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01980823 2023-08-30
Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer
Columbia University
Phase EARLY_PHASE1 Completed
NCT01555632 2023-08-14
Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy
University of Nebraska
Phase NA Withdrawn
NCT05103644 2022-11-02
Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"
Beni-Suef University
Phase 2/3 Unknown
NCT05507398 2022-10-31
The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer
Tanta University
Phase 4 Unknown
NCT04026230 2022-10-21
ESTO2
Tampere University Hospital
Phase 3 Unknown
NCT02201381 2022-07-18
METRICS
Health Clinics Limited
Phase 3 Withdrawn
NCT03186404 2022-02-08
SPARE-HF
University Health Network, Toronto
Phase 2 Unknown
NCT01759836 2022-01-25
Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer
Asan Medical Center
Phase 2 Completed
NCT01988571 2022-01-04
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Wake Forest University Health Sciences
Phase 2 Completed
NCT03066466 2021-04-27
Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT
Loyola University
Phase 3 Withdrawn
NCT02497638 2021-04-19
LIGAND
University Health Network, Toronto
Phase 2 Withdrawn
NCT03275376 2021-03-16
Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma
Taichung Veterans General Hospital
Phase 2 Terminated
NCT04601116 2021-01-14
The MASTER Study (MAmmary Cancer STatin ER Positive Study)
Aarhus University Hospital
Phase 3 Recruiting
NCT02767362 2020-07-07
A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT04151355 2019-11-05
Effect of Atorvastatin on 5-Fluorouracil Induced Mucositis
Ain Shams University
Phase NA Unknown
NCT02674204 2019-05-15
STOP
Cedars-Sinai Medical Center
Phase 2 Terminated
NCT01220973 2018-06-08
Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
Rutgers, The State University of New Jersey
Phase 2 Completed
NCT01821404 2018-05-07
ESTO1
Tampere University Hospital
Phase 2 Completed
NCT02022293 2017-12-04
Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Suspended
NCT00185731 2017-12-02
Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma
Stanford University
Phase 2 Completed
NCT02029573 2017-08-18
ART
King Fahad Medical City
Phase 2 Completed
NCT00335504 2017-02-15
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia
National Cancer Institute (NCI)
Phase 2 Completed
NCT00637481 2016-12-29
A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT01733953 2016-12-14
Statin Therapy in Young Adult Survivors of Childhood Cancer
University of Minnesota
Phase 2 Completed
NCT00259662 2016-12-01
High-dose Periop Statins for Prevention of DVT
Yale University
Phase NA Completed
NCT02093390 2016-06-06
A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects
Millennium Pharmaceuticals, Inc.
Phase 1 Completed
NCT02416427 2015-04-15
TRINACRIA
Regina Elena Cancer Institute
Phase 2 Unknown
NCT00529542 2014-09-25
A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol
Milton S. Hershey Medical Center
Phase 2 Completed
NCT01605344 2014-02-27
Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
UNC Lineberger Comprehensive Cancer Center
Phase 1 Withdrawn
NCT00490698 2013-03-18
Zoledronate With Atorvastatin in Renal Cell Carcinoma
M.D. Anderson Cancer Center
Phase 2 Completed